Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...